{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:16:14Z","timestamp":1789848974987,"version":"4.0.1"},"reference-count":178,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005716","name":"Babol University of Medical Sciences","doi-asserted-by":"publisher","award":["404000069"],"award-info":[{"award-number":["404000069"]}],"id":[{"id":"10.13039\/501100005716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.intimp.2026.116991","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:50:36Z","timestamp":1781542236000},"page":"116991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Macrophage plasticity as a therapeutic target in inflammatory bowel disease: Immunomodulatory and regenerative strategies"],"prefix":"10.1016","volume":"185","author":[{"given":"Fatemeh","family":"Nasimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ashtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Moafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Baneshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reihane","family":"Feizollah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Samadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116991_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065186","article-title":"Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the global burden of disease study 2019","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.intimp.2026.116991_bb0015","first-page":"132","article-title":"Global prevalence and incidence of inflammatory bowel disease: a systematic review and meta-analysis of population-based studies","volume":"18","author":"Heydari","year":"2025","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"issue":"3","key":"10.1016\/j.intimp.2026.116991_bb0020","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10620-020-06112-w","article-title":"Diet and the human gut microbiome: an international review","volume":"65","author":"Wilson","year":"2020","journal-title":"Dig. Dis. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2026.116991_bb0025","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41575-018-0003-z","article-title":"Urbanization and the gut microbiota in health and inflammatory bowel disease","volume":"15","author":"Zuo","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116991_bb0030","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1007\/s11033-020-05318-5","article-title":"Inflammatory bowel disease: between genetics and microbiota","volume":"47","author":"Younis","year":"2020","journal-title":"Mol. Biol. Rep."},{"issue":"9","key":"10.1016\/j.intimp.2026.116991_bb0035","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.cgh.2019.08.042","article-title":"Rate of risk factors for and interventions to reduce hospital readmission in patients with inflammatory bowel diseases","volume":"18","author":"Nguyen","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116991_bb0040","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1007\/s10620-021-07200-1","article-title":"Systematic review and Meta-analysis: risk of hospitalization in patients with ulcerative colitis and Crohn's disease in population-based cohort studies","volume":"67","author":"Tsai","year":"2022","journal-title":"Dig. Dis. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2026.116991_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052789","article-title":"Cellular and molecular determinants of biologic drugs resistance and therapeutic failure in inflammatory bowel disease","volume":"25","author":"Puca","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116991_bb0050","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/nrdp.2016.14","article-title":"Irritable bowel syndrome","volume":"2","author":"Enck","year":"2016","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"2","key":"10.1016\/j.intimp.2026.116991_bb0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cgh.2018.07.012","article-title":"Environmental factors, gut microbiota, and colorectal Cancer prevention","volume":"17","author":"Song","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrgastro.2017.136","article-title":"Environmental triggers in IBD: a review of progress and evidence","volume":"15","author":"Ananthakrishnan","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7351","key":"10.1016\/j.intimp.2026.116991_bb0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10208","article-title":"Intestinal homeostasis and its breakdown in inflammatory bowel disease","volume":"474","author":"Maloy","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/imr.12192","article-title":"Macrophages in intestinal homeostasis and inflammation","volume":"260","author":"Bain","year":"2014","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12964-023-01386-9","article-title":"Macrophage polarization in inflammatory bowel disease","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"8","key":"10.1016\/j.intimp.2026.116991_bb0080","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","article-title":"Macrophages in intestinal homeostasis and inflammatory bowel disease","volume":"20","author":"Hegarty","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0085","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1038\/s41467-023-40156-6","article-title":"Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease","volume":"14","author":"Garrido-Trigo","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2026.116991_bb0090","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41435-023-00242-7","article-title":"Uncovering intestinal macrophages through the integration of single-cell and spatial transcriptomics","volume":"25","author":"Garrido-Trigo","year":"2024","journal-title":"Genes & Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2026.116991_bb0095","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.immuni.2019.03.017","article-title":"Cytokine networks in the pathophysiology of inflammatory bowel disease","volume":"50","author":"Friedrich","year":"2019","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.intimp.2026.116991_bb0100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41575-019-0172-4","article-title":"Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD","volume":"16","author":"Na","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40364-024-00612-x","article-title":"Monocyte-macrophages modulate intestinal homeostasis in inflammatory bowel disease","volume":"12","author":"Lu","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.intimp.2026.116991_bb0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jare.2021.07.002","article-title":"Extracellular vesicles-mediated interaction within intestinal microenvironment in inflammatory bowel disease","volume":"37","author":"Shen","year":"2022","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.intimp.2026.116991_bb0115","doi-asserted-by":"crossref","first-page":"1696524","DOI":"10.3389\/fmicb.2025.1696524","article-title":"Engineered probiotics for inflammatory bowel disease therapy: mechanisms, delivery strategies, and precision medicine","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Microbiol."},{"issue":"18","key":"10.1016\/j.intimp.2026.116991_bb0120","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.3748\/wjg.v25.i18.2177","article-title":"Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease","volume":"25","author":"Limanskiy","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116991_bb0125","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.07.048","article-title":"Self-maintaining gut macrophages are essential for intestinal homeostasis","volume":"175","author":"De Schepper","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1172\/JCI200519229","article-title":"Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity","volume":"115","author":"Smythies","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.116991_bb0135","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.3389\/fimmu.2018.02733","article-title":"Origin, differentiation, and function of intestinal macrophages","volume":"9","author":"Bain","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116991_bb0140","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fimmu.2019.00276","article-title":"NLRP3 inflammasome and inflammatory bowel disease","volume":"10","author":"Zhen","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116991_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108176","article-title":"Macrophage immunometabolism in inflammatory bowel diseases: from pathogenesis to therapy","volume":"238","author":"Pan","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2026.116991_bb0150","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3389\/fimmu.2019.01462","article-title":"The metabolic signature of macrophage responses","volume":"10","author":"Viola","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116991_bb0155","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annu. Rev. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116991_bb0160","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","article-title":"Transcriptome-based network analysis reveals a spectrum model of human macrophage activation","volume":"40","author":"Xue","year":"2014","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2026.116991_bb0165","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41385-021-00470-y","article-title":"Redefining intestinal immunity with single-cell transcriptomics","volume":"15","author":"James","year":"2022","journal-title":"Mucosal Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116991_bb0170","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.cell.2019.08.008","article-title":"Single-cell analysis of Crohn's disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy","volume":"178","author":"Martin","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.intimp.2026.116991_bb0175","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.intimp.2026.116991_bb0180","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13843","article-title":"Intestinal resident macrophages: multitaskers of the gut","volume":"32","author":"Viola","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0185","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12964-025-02065-7","article-title":"Modulation of \u03b2-catenin promotes WNT expression in macrophages and mitigates intestinal injury","volume":"23","author":"Chugh","year":"2025","journal-title":"Cell Communication and Signaling"},{"key":"10.1016\/j.intimp.2026.116991_bb0190","doi-asserted-by":"crossref","unstructured":"Cos\u00edn-Roger, J., et al., M\u03b2 Macrophages Activate WNT Signaling Pathway in Epithelial Cells: Relevance in Ulcerative Colitis. PLoS ONE. 8(10): e781\u03b28.","DOI":"10.1371\/journal.pone.0078128"},{"key":"10.1016\/j.intimp.2026.116991_bb0195","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.2147\/JIR.S470520","article-title":"Restore intestinal barrier integrity: an approach for inflammatory bowel disease therapy","author":"Kong","year":"2024","journal-title":"J. Inflamm. Res."},{"issue":"10","key":"10.1016\/j.intimp.2026.116991_bb0200","first-page":"4117","article-title":"Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP","volume":"112","author":"Bystrom","year":"2008","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"2","key":"10.1016\/j.intimp.2026.116991_bb0205","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016311","article-title":"Lipid mediators in the resolution of inflammation","volume":"7","author":"Serhan","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116991_bb0210","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5009\/gnl220045","article-title":"Cellular and molecular mechanisms of intestinal fibrosis","volume":"17","author":"Wu","year":"2023","journal-title":"Gut Liver"},{"issue":"2","key":"10.1016\/j.intimp.2026.116991_bb0215","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3390\/ijms27021095","article-title":"Gut microbiota-derived short-chain fatty acids in inflammatory bowel disease: mechanistic insights into gut inflammation, barrier function, and therapeutic potential","volume":"27","author":"Ottria","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.116991_bb0220","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","article-title":"The short chain fatty acid butyrate imprints an antimicrobial program in macrophages","volume":"50","author":"Schulthess","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116991_bb0225","doi-asserted-by":"crossref","first-page":"0294","DOI":"10.34133\/bmr.0294","article-title":"Targeting microbe-mediated macrophage education: a novel paradigm in Cancer immunotherapy","volume":"29","author":"Xu","year":"2025","journal-title":"Biomater. Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.116991_bb0230","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3390\/microorganisms10030490","article-title":"Gut microbiota, macrophages and diet: an intriguing new triangle in intestinal fibrosis","volume":"10","author":"Amamou","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.intimp.2026.116991_bb0235","doi-asserted-by":"crossref","first-page":"1778244","DOI":"10.3389\/fcimb.2026.1778244","article-title":"Gut microbiota and macrophage crosstalk: implications for colitis-associated colorectal cancer","volume":"16","author":"Lyu","year":"2026","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0240","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s43556-025-00395-z","article-title":"Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives","volume":"7","author":"Yang","year":"2026","journal-title":"Molecular Biomedicine"},{"key":"10.1016\/j.intimp.2026.116991_bb0245","doi-asserted-by":"crossref","first-page":"1786701","DOI":"10.3389\/fmicb.2026.1786701","article-title":"Tongxie Yaofang ameliorates IBS-D by targeting the gut microbiota-derived tryptophan metabolites and AhR signaling axis","volume":"17","author":"Xie","year":"2026","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2026.116991_bb0250","doi-asserted-by":"crossref","first-page":"11821","DOI":"10.2147\/JIR.S534447","article-title":"Macrophage metabolic reprogramming in inflammatory bowel diseases: from pathogenesis to therapy","author":"Zhang","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2026.116991_bb0255","doi-asserted-by":"crossref","first-page":"1772110","DOI":"10.3389\/fimmu.2026.1772110","article-title":"The central regulator HIF-1\u03b1 in digestive system pathologies: inflammation and cancer","volume":"17","author":"Gou","year":"2026","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116991_bb0260","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41422-020-0291-z","article-title":"Targeting immunometabolism as an anti-inflammatory strategy","volume":"30","author":"P\u00e5lsson-McDermott","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2026.116991_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115801","article-title":"Mesenchymal stem cells regulating macrophage polarization","volume":"168","author":"Li","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116991_bb0270","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jconrel.2016.07.018","article-title":"Macrophage-based cell therapies: the long and winding road","volume":"240","author":"Lee","year":"2016","journal-title":"J. Control. Release"},{"issue":"37","key":"10.1016\/j.intimp.2026.116991_bb0275","doi-asserted-by":"crossref","first-page":"25657","DOI":"10.1021\/acsnano.4c07750","article-title":"Oral microto-Nano genome-editing system enabling targeted delivery and conditional activation of CRISPR-Cas9 for gene therapy of inflammatory bowel disease","volume":"18","author":"Lin","year":"2024","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.intimp.2026.116991_bb0280","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/emmm.201202382","article-title":"Resolution of inflammation: an integrated view","volume":"5","author":"Ortega-G\u00f3mez","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.intimp.2026.116991_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.625423","article-title":"Roles of macrophages in the development and treatment of gut inflammation","volume":"9","author":"Han","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.intimp.2026.116991_bb0290","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/ibd\/izae046","article-title":"Hypoxic functional regulation pathways in the GI tract: focus on the HIF-1\u03b1 and microbiota's crosstalk","volume":"30","author":"Di Mattia","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0295","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cmet.2006.05.011","article-title":"Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation","volume":"4","author":"Vats","year":"2006","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0300","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1186\/s12967-023-04772-6","article-title":"The role of AMPK in macrophage metabolism, function and polarisation","volume":"21","author":"Cui","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2026.116991_bb0305","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fimmu.2018.00270","article-title":"Metabolic modulation in macrophage effector function","volume":"9","author":"Diskin","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116991_bb0310","first-page":"785","article-title":"Advances in macrophage-targeting nanoparticles for the diagnosis and treatment of inflammatory bowel disease","volume":"52","author":"Liu","year":"2023","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.intimp.2026.116991_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114466","article-title":"Targeted therapeutics for IBD unraveling the potential of stimulus-responsive nanoparticles","volume":"389","author":"Barros","year":"2026","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.intimp.2026.116991_bb0320","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.smim.2015.08.001","article-title":"Control of macrophage metabolism and activation by mTOR and Akt signaling","volume":"27","author":"Covarrubias","year":"2015","journal-title":"Semin. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116991_bb0325","doi-asserted-by":"crossref","first-page":"437","DOI":"10.5152\/tjg.2023.22515","article-title":"Epigenetics of inflammatory bowel diseases","volume":"34","author":"T\u00f6r\u00fcner","year":"2023","journal-title":"Turk. J. Gastroenterol."},{"key":"10.1016\/j.intimp.2026.116991_bb0330","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3389\/fimmu.2019.00799","article-title":"MicroRNAs as molecular switches in macrophage activation","volume":"10","author":"Curtale","year":"2019","journal-title":"Front. Immunol."},{"issue":"6437","key":"10.1016\/j.intimp.2026.116991_bb0335","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.aav9023","article-title":"Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq","volume":"364","author":"Wienert","year":"2019","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.intimp.2026.116991_bb0340","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","article-title":"Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing","volume":"53","author":"Leibowitz","year":"2021","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.intimp.2026.116991_bb0345","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41577-024-01008-6","article-title":"Strategies for targeting cytokines in inflammatory bowel disease","volume":"24","author":"Neurath","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116991_bb0350","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/s12276-023-01068-z","article-title":"A new era of macrophage-based cell therapy","volume":"55","author":"Na","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2026.116991_bb0355","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jconrel.2024.01.051","article-title":"Nanotechnology-enabled M2 macrophage polarization and ferroptosis inhibition for targeted inflammatory bowel disease treatment","volume":"367","author":"Zhao","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2026.116991_bb0360","doi-asserted-by":"crossref","first-page":"1523052","DOI":"10.3389\/fphar.2024.1523052","article-title":"Analysis of nanomedicine applications for inflammatory bowel disease: structural and temporal dynamics, research hotspots, and emerging trends","volume":"15","author":"Jiang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116991_bb0365","doi-asserted-by":"crossref","first-page":"103078","DOI":"10.1016\/j.mtbio.2026.103078","article-title":"Self-assembled nanoparticles from Xiexin Decoction attenuate ulcerative colitis by targeting VDAC1-Mediated NLRP3 inflammasome activation","volume":"38","author":"Chu","year":"2026","journal-title":"Mater Today Bio"},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0370","doi-asserted-by":"crossref","first-page":"2580730","DOI":"10.1080\/10717544.2025.2580730","article-title":"Nanotechnology-based targeted regulation of NLRP3 inflammasome: therapeutic strategies and clinical application prospects in inflammatory diseases","volume":"32","author":"Zhao","year":"2025","journal-title":"Drug Deliv."},{"issue":"10","key":"10.1016\/j.intimp.2026.116991_bb0375","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.7150\/thno.124748","article-title":"Macrophage membrane-biomimetic cinnamaldehyde nanomedicine ameliorates inflammatory bowel disease by suppressing macrophage M1 polarization","volume":"16","author":"Huang","year":"2026","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.intimp.2026.116991_bb0380","doi-asserted-by":"crossref","first-page":"2400275","DOI":"10.1002\/adtp.202400275","article-title":"Probiotics-loaded selenium nanoparticles effectively alleviated DSS-induced colitis by scavenging ROS and Remodeling intestinal innate immune and microbiota","volume":"7","author":"Yao","year":"2024","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0385","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1186\/s12951-024-02861-2","article-title":"Mannose coated selenium nanoparticles normalize intestinal homeostasis in mice and mitigate colitis by inhibiting NF-\u03baB activation and enhancing glutathione peroxidase expression","volume":"22","author":"Yang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2026.116991_bb0390","doi-asserted-by":"crossref","first-page":"13925","DOI":"10.2147\/IJN.S497590","article-title":"Application of nanomaterials targeting immune cells in the treatment of chronic inflammation","author":"Ci","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.intimp.2026.116991_bb0395","series-title":"Chitosan and Alginate Frontiers-Innovations and Applications in Life Sciences, Food, and Industry","article-title":"Biomedical potential of chitosan nanoparticles: Advances in drug delivery and disease management","author":"Srinivasan","year":"2026"},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0400","doi-asserted-by":"crossref","first-page":"2219427","DOI":"10.1080\/10717544.2023.2219427","article-title":"Responsive nanosystems for targeted therapy of ulcerative colitis: current practices and future perspectives","volume":"30","author":"Chen","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.intimp.2026.116991_bb0405","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2147\/DDDT.S461977","article-title":"Nanoparticle-based drug delivery systems for inflammatory bowel disease treatment","author":"Gao","year":"2024","journal-title":"Drug Des. Devel. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2026.116991_bb0410","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/biomedicines10020413","article-title":"Utilizing sphingomyelinase sensitizing liposomes in imaging intestinal inflammation in dextran sulfate sodium-induced murine colitis","volume":"10","author":"Penate Medina","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.intimp.2026.116991_bb0415","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/ijms26020575","article-title":"Advancing inflammatory bowel disease treatment by targeting the innate immune system and precision drug delivery","volume":"26","author":"Kiilerich","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.116991_bb0420","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1248\/bpb.b23-00769","article-title":"Oral administration of PLGA nanoparticles to deliver antisense oligonucleotides to inflammatory lesions in the gastrointestinal tract","volume":"47","author":"Yagi","year":"2024","journal-title":"Biol. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.intimp.2026.116991_bb0425","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000519363","article-title":"Macrophage-biomimetic nanoparticles ameliorate ulcerative colitis through reducing inflammatory factors expression","volume":"14","author":"Li","year":"2022","journal-title":"J. Innate Immun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0430","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12951-024-02501-9","article-title":"Reactive oxygen species-scavenging nanomaterials for the prevention and treatment of age-related diseases","volume":"22","author":"Dai","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116991_bb0435","doi-asserted-by":"crossref","first-page":"98732","DOI":"10.3748\/wjg.v31.i5.98732","article-title":"Hollow cerium nanoparticles synthesized by one-step method for multienzyme activity to reduce colitis in mice","volume":"31","author":"Mi","year":"2025","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0440","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10856-025-06989-x","article-title":"Study on the antioxidant and anti-inflammatory properties of different morphologies of ceria nanoenzymes with multi enzyme mimetic activity","volume":"37","author":"Song","year":"2026","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.intimp.2026.116991_bb0445","series-title":"Bioinspired Approaches to Precision Nanomedicine","author":"Williamson","year":"2026"},{"issue":"12","key":"10.1016\/j.intimp.2026.116991_bb0450","first-page":"6970","article-title":"Exosome-mediated macrophage regulation for inflammatory bowel disease repair: a potential target of gut inflammation","volume":"15","author":"Ma","year":"2023","journal-title":"Am. J. Transl. Res."},{"issue":"6","key":"10.1016\/j.intimp.2026.116991_bb0455","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.7150\/thno.91394","article-title":"Nanotechnology in inflammation: cutting-edge advances in diagnostics, therapeutics and theranostics","volume":"14","author":"Liu","year":"2024","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.intimp.2026.116991_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajps.2024.100943","article-title":"Design strategies, advances and future perspectives of colon-targeted delivery systems for the treatment of inflammatory bowel disease","volume":"19","author":"Zheng","year":"2024","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"issue":"15","key":"10.1016\/j.intimp.2026.116991_bb0465","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1039\/D4CS00421C","article-title":"Lymphoid organ-targeted nanomaterials for immunomodulation of cancer, inflammation, and beyond","volume":"53","author":"Hsu","year":"2024","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.intimp.2026.116991_bb0470","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fimmu.2020.00218","article-title":"Targeting of hepatic macrophages by therapeutic nanoparticles","volume":"11","author":"Colino","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116991_bb0475","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/nano15060435","article-title":"Synthesis, characterization, and stability study of selenium nanoparticles coated with purified polysaccharides from Ononis natrix","volume":"15","author":"Bhiri","year":"2025","journal-title":"Nanomaterials"},{"key":"10.1016\/j.intimp.2026.116991_bb0480","doi-asserted-by":"crossref","first-page":"1183487","DOI":"10.3389\/fnut.2023.1183487","article-title":"Recent research progress on the synthesis and biological effects of selenium nanoparticles","volume":"10","author":"Zhang","year":"2023","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0485","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"11","key":"10.1016\/j.intimp.2026.116991_bb0490","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2026.116991_bb0495","article-title":"TREM2+ macrophages: a key role in disease development","volume":"16","author":"Wang","year":"2025","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"10.1016\/j.intimp.2026.116991_bb0500","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.349","article-title":"Signaling pathways in macrophages: molecular mechanisms and therapeutic targets","volume":"4","author":"Li","year":"2023","journal-title":"MedComm"},{"issue":"4","key":"10.1016\/j.intimp.2026.116991_bb0505","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.7150\/thno.50683","article-title":"The twin cytokines interleukin-34 and CSF-1: masterful conductors of macrophage homeostasis","volume":"11","author":"Mu\u00f1oz-Garcia","year":"2021","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.intimp.2026.116991_bb0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056951","article-title":"CSF-1 receptor-dependent colon development, homeostasis and inflammatory stress response","volume":"8","author":"Huynh","year":"2013","journal-title":"PloS one"},{"issue":"4","key":"10.1016\/j.intimp.2026.116991_bb0515","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.3390\/cimb46040180","article-title":"Blocking Microglial Proliferation by CSF-1R Inhibitor Does Not Alter the Neuroprotective Effects of Adoptive Regulatory T Cells in 3xTg Alzheimer's Disease Mice","volume":"46","author":"Park","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.intimp.2026.116991_bb0520","doi-asserted-by":"crossref","first-page":"654817","DOI":"10.3389\/fonc.2021.654817","article-title":"Colony stimulating factor 1 receptor in acute myeloid leukemia","volume":"11","author":"Sletta","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116991_bb0525","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/jpp\/rgad112","article-title":"Targeting the CCL2\u2013CCR2 signaling pathway: potential implications of statins beyond cardiovascular diseases","volume":"76","author":"Gholamalizadeh","year":"2024","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116991_bb0530","article-title":"Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116991_bb0535","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1111\/cas.14075","article-title":"Potentials of C-C motif chemokine 2\u2013C-C chemokine receptor type 2 blockers including propagermanium as anticancer agents","volume":"110","author":"Yumimoto","year":"2019","journal-title":"Cancer science"},{"key":"10.1016\/j.intimp.2026.116991_bb0540","doi-asserted-by":"crossref","first-page":"956691","DOI":"10.3389\/fimmu.2022.956691","article-title":"Role of periostin in inflammatory bowel disease development and synergistic effects mediated by the CCL5\u2013CCR5 axis","volume":"13","author":"Mukanova","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.intimp.2026.116991_bb0545","doi-asserted-by":"crossref","DOI":"10.1038\/srep30802","article-title":"Highly specific blockade of CCR5 inhibits leukocyte trafficking and reduces mucosal inflammation in murine colitis","volume":"6","author":"Mencarelli","year":"2016","journal-title":"Sci Rep."},{"key":"10.1016\/j.intimp.2026.116991_bb0550","doi-asserted-by":"crossref","first-page":"318730","DOI":"10.3389\/fimmu.2017.01981","article-title":"The expanding therapeutic perspective of CCR5 blockade","volume":"8","author":"Vangelista","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116991_bb0555","volume":"13","author":"Che","year":"2026","journal-title":"Neurology: Neuroimmunology & Neuroinflammation Neurology: Neuroimmunology & Neuroinflammation"},{"issue":"3","key":"10.1016\/j.intimp.2026.116991_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/cancers18030359","article-title":"TREM2 in Urological Malignancies and Benign Lesions: Mechanistic Convergence, Functional Heterogeneity, and Translational Perspectives: A Narrative Review","volume":"18","author":"Dai","year":"2026","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.intimp.2026.116991_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012543","article-title":"Trem2\/Syk\/PI3K axis contributes to the host protection against Toxoplasma gondii-induced adverse pregnancy outcomes via modulating decidual macrophages","volume":"20","author":"Wang","year":"2024","journal-title":"PLoS pathogens"},{"issue":"2","key":"10.1016\/j.intimp.2026.116991_bb0570","doi-asserted-by":"crossref","first-page":"102580","DOI":"10.1016\/j.xcrm.2025.102580","article-title":"Synthetic cleavage-resistant TREM2 boosts macrophage efferocytosis to treat inflammatory diseases","volume":"7","author":"Dong","year":"2026","journal-title":"Cell Rep. Med."},{"issue":"95","key":"10.1016\/j.intimp.2026.116991_bb0575","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi5374","article-title":"TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti\u2013PD-1 tumor immunotherapy","volume":"9","author":"Di Luccia","year":"2024","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0580","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s11658-022-00384-y","article-title":"The role of macrophage subtypes and exosomes in immunomodulation","volume":"27","author":"Gharavi","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"3","key":"10.1016\/j.intimp.2026.116991_bb0585","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/cancers16030574","article-title":"The oncogenic lipid sphingosine-1-phosphate impedes the phagocytosis of tumor cells by m1 macrophages in diffuse large b cell lymphoma","volume":"16","author":"Perry","year":"2024","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.intimp.2026.116991_bb0590","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/jleuko\/qiad165","article-title":"Intestinal macrophages in pathogenesis and treatment of gut leakage: current strategies and future perspectives","volume":"115","author":"Selvakumar","year":"2024","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2026.116991_bb0595","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ebiom.2018.03.030","article-title":"Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model","volume":"30","author":"Chen","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2026.116991_bb0600","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202600074","article-title":"Human Colitis-on-Chip Model Reveals Dual Roles of Butyrate in Epithelial and Macrophage Defense Against Candida albicans Tissue Invasion","author":"Allwang","year":"2026","journal-title":"Small"},{"issue":"15","key":"10.1016\/j.intimp.2026.116991_bb0605","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.3390\/cells11152296","article-title":"Gut microbiota-derived tryptophan metabolites maintain gut and systemic homeostasis","volume":"11","author":"Su","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0610","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41392-025-02500-8","article-title":"The aryl hydrocarbon receptor: structure, signaling, physiology and pathology","volume":"11","author":"Coumoul","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.116991_bb0615","doi-asserted-by":"crossref","first-page":"1607899","DOI":"10.3389\/fmed.2025.1607899","article-title":"Bile acids affect intestinal barrier function through FXR and TGR5","volume":"12","author":"Song","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.intimp.2026.116991_bb0620","doi-asserted-by":"crossref","first-page":"1710880","DOI":"10.3389\/fimmu.2025.1710880","article-title":"Gut microbiota\u2013derived metabolites in immunomodulation and gastrointestinal cancer immunotherapy","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0625","doi-asserted-by":"crossref","first-page":"14494","DOI":"10.1038\/s41598-023-41182-6","article-title":"Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis","volume":"13","author":"Feng","year":"2023","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2026.116991_bb0630","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3390\/biomedicines11041016","article-title":"Fecal microbiota transplantation in inflammatory bowel disease","volume":"11","author":"Boicean","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.intimp.2026.116991_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42430","article-title":"Effect of fecal microbiota transplantation on ulcerative colitis model in rats: The gut\u2013brain axis","volume":"11","author":"Morshedbak","year":"2025","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0640","doi-asserted-by":"crossref","DOI":"10.1093\/ismejo\/wrag028","article-title":"Gut microbial production of lithocholic acid reprograms pro-resolutive macrophages to enhance vedolizumab responsiveness via the TGR5\/FXR\u2013NF-\u03baB axis","volume":"20","author":"Han","year":"2025","journal-title":"The ISME Journal"},{"issue":"4","key":"10.1016\/j.intimp.2026.116991_bb0645","article-title":"Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Systematic Review of Efficacy and Safety","volume":"18","author":"Busmail","year":"2026","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.intimp.2026.116991_bb0650","article-title":"Bioinspired and bioderived nanomedicine for inflammatory bowel disease","volume":"16","author":"Gazzi","year":"2024","journal-title":"Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology"},{"issue":"4","key":"10.1016\/j.intimp.2026.116991_bb0655","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1039\/D3BM01645E","article-title":"Advancements in hydrogel-based drug delivery systems for the treatment of inflammatory bowel disease: a review","volume":"12","author":"Liu","year":"2024","journal-title":"Biomater. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2026.116991_bb0660","doi-asserted-by":"crossref","first-page":"G693","DOI":"10.1152\/ajpgi.00043.2021","article-title":"Intestinal organoids in coculture: redefining the boundaries of gut mucosa ex vivo modeling","volume":"321","author":"Hentschel","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0665","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/cei\/uxad118","article-title":"Organoids as a tool to study homeostatic and pathological immune\u2013epithelial interactions in the gut","volume":"218","author":"Kromann","year":"2024","journal-title":"Clin. Exp. Immunol."},{"issue":"20","key":"10.1016\/j.intimp.2026.116991_bb0670","doi-asserted-by":"crossref","first-page":"10161","DOI":"10.3390\/ijms262010161","article-title":"Berberine Alleviates Intestinal Inflammation by Disrupting Pathological Macrophage\u2013Epithelial Crosstalk in Macrophage\u2013Organoid Co-Culture Model","volume":"26","author":"Han","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116991_bb0675","doi-asserted-by":"crossref","first-page":"623691","DOI":"10.3389\/fimmu.2020.623691","article-title":"Intestinal stem cells and immune cell relationships: potential therapeutic targets for inflammatory bowel diseases","volume":"11","author":"Hou","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0680","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev-immunol-101721-062818","article-title":"Immune-epithelial cross talk in regeneration and repair","volume":"41","author":"Guenin-Mace","year":"2023","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116991_bb0685","doi-asserted-by":"crossref","DOI":"10.1093\/lifemedi\/lnaf012","article-title":"Advances and applications of gut organoids: modeling intestinal diseases and therapeutic development","volume":"4","author":"Xu","year":"2025","journal-title":"Life Medicine"},{"issue":"24","key":"10.1016\/j.intimp.2026.116991_bb0690","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.3748\/wjg.v28.i24.2636","article-title":"Patient-derived organoids for therapy personalization in inflammatory bowel diseases","volume":"28","author":"Lucaf\u00f2","year":"2022","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.intimp.2026.116991_bb0695","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fmed.2019.00334","article-title":"Intestinal organoids as a tool for inflammatory bowel disease research","volume":"6","author":"Angus","year":"2020","journal-title":"Frontiers in medicine"},{"issue":"7","key":"10.1016\/j.intimp.2026.116991_bb0700","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/ecco-jcc\/jjaa257","article-title":"Organoid-based models to study the role of host-microbiota interactions in IBD","volume":"15","author":"Poletti","year":"2021","journal-title":"Journal of Crohn's and Colitis"},{"issue":"10","key":"10.1016\/j.intimp.2026.116991_bb0705","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/jpm15100492","article-title":"Recent Insights into Organoid-Derived Extracellular Vesicles and Their Biomedical Applications","volume":"15","author":"Abdal Dayem","year":"2025","journal-title":"J Pers Med"},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0710","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1186\/s12951-024-02917-3","article-title":"Organoids and organoid extracellular vesicles-based disease treatment strategies","volume":"22","author":"Zhou","year":"2024","journal-title":"Journal of Nanobiotechnology"},{"key":"10.1016\/j.intimp.2026.116991_bb0715","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jot.2025.05.008","article-title":"Combination therapy using intestinal organoids and their extracellular vesicles for inflammatory bowel disease complicated with osteoporosis","volume":"53","author":"Wang","year":"2025","journal-title":"Journal of Orthopaedic Translation"},{"issue":"6","key":"10.1016\/j.intimp.2026.116991_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110118","article-title":"Organoids as regenerative medicine for inflammatory bowel disease","volume":"27","author":"Hammerh\u00f8j","year":"2024","journal-title":"IScience"},{"key":"10.1016\/j.intimp.2026.116991_bb0725","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1038\/s41467-023-42502-0","article-title":"Organoids transplantation attenuates intestinal ischemia\/reperfusion injury in mice through L-Malic acid-mediated M2 macrophage polarization","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.intimp.2026.116991_bb0730","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/ibd\/izad044","article-title":"Therapeutic potential of human intestinal organoids in tissue repair approaches in inflammatory bowel diseases","volume":"29","author":"Rutherford","year":"2023","journal-title":"Inflammatory Bowel Diseases"},{"issue":"3","key":"10.1016\/j.intimp.2026.116991_bb0735","first-page":"205","article-title":"Hydrogel microspheres for bone regeneration through regulation of the regenerative microenvironment","volume":"5","author":"Zhang","year":"2024","journal-title":"Biomaterials translational"},{"issue":"3","key":"10.1016\/j.intimp.2026.116991_bb0740","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/cells13030210","article-title":"Enhancing immunomodulatory function of mesenchymal stromal cells by hydrogel encapsulation","volume":"13","author":"Cheng","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.116991_bb0745","doi-asserted-by":"crossref","first-page":"102944","DOI":"10.1016\/j.mtbio.2026.102944","article-title":"Bioresponsive PDA-GelMA hydrogel microspheres coordinate redox-immune homeostasis via controlled rhMUC13 delivery for radiation-induced intestinal injury","volume":"37","author":"Ling","year":"2026","journal-title":"Mater. Today Bio."},{"issue":"10","key":"10.1016\/j.intimp.2026.116991_bb0750","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.3390\/ijms27104508","article-title":"Macrophages in Intestinal Wound Healing: Dichotomous Effects and Therapeutic Opportunities","volume":"27","author":"Bungert","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2026.116991_bb0755","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.3390\/ijms26072894","article-title":"Recent advances in the application of hydrogels as drug carriers in inflammatory bowel disease: A review","volume":"26","author":"Zhang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0760","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12951-023-02045-4","article-title":"Oral hydrogel nanoemulsion co-delivery system treats inflammatory bowel disease via anti-inflammatory and promoting intestinal mucosa repair","volume":"21","author":"Lei","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116991_bb0765","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1021\/acsomega.3c08280","article-title":"Extracellular vesicles and hydrogels: an innovative approach to tissue regeneration","volume":"9","author":"Hashemi","year":"2024","journal-title":"ACS omega"},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0770","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13287-022-02811-5","article-title":"The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer","volume":"13","author":"Guo","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.intimp.2026.116991_bb0775","first-page":"55","article-title":"Macrophage based drug delivery: key challenges and strategies","volume":"38","author":"Guo","year":"2024","journal-title":"Bioact. Mater."},{"issue":"9","key":"10.1016\/j.intimp.2026.116991_bb0780","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/pharmaceutics13091340","article-title":"Nanoparticles to target and treat macrophages: the Ockham's concept?","volume":"13","author":"Medrano-Bosch","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.intimp.2026.116991_bb0785","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.3390\/ijms26072855","article-title":"The Intestinal Macrophage\u2013Intestinal Stem Cell Axis in Inflammatory Bowel Diseases: From Pathogenesis to Therapy","volume":"26","author":"Quan","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116991_bb0790","doi-asserted-by":"crossref","first-page":"1837255","DOI":"10.3389\/fimmu.2026.1837255","article-title":"Macrophage dysregulation in inflammatory bowel disease: cellular heterogeneity, pathogenic mechanism, and treatment","volume":"17","author":"Yang","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116991_bb0795","doi-asserted-by":"crossref","first-page":"1719366","DOI":"10.3389\/fimmu.2025.1719366","article-title":"Deciphering the immunocellular regulatory network in inflammatory bowel disease: from susceptibility genes to cellular effectors and toward precision therapies","volume":"16","author":"Wu","year":"2026","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0800","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s12967-026-07853-4","article-title":"Integrated single-cell and spatial transcriptomics uncover SPP1+ and HLA-DRB5+ macrophages as key modulators of the immune microenvironment in colorectal cancer liver metastasis","volume":"24","author":"Xie","year":"2026","journal-title":"J Transl Med"},{"key":"10.1016\/j.intimp.2026.116991_bb0805","doi-asserted-by":"crossref","first-page":"1719902","DOI":"10.3389\/fimmu.2026.1719902","article-title":"Single-nucleus and spatial transcriptomics reveal intestinal cellular heterogeneity, differentiation, and cell communication mechanisms in SAP-induced intestinal injury","volume":"17","author":"Zhang","year":"2026","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116991_bb0810","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1136\/gutjnl-2023-331579","article-title":"Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia","volume":"73","author":"Iacucci","year":"2024","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.intimp.2026.116991_bb0815","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/gels11080584","article-title":"Hydrogels modulating the microbiome: therapies for tissue regeneration with infection control","volume":"11","author":"Jim\u00e9nez-Gastelum","year":"2025","journal-title":"Gels"},{"key":"10.1016\/j.intimp.2026.116991_bb0820","doi-asserted-by":"crossref","first-page":"1045575","DOI":"10.3389\/fphar.2022.1045575","article-title":"Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory bowel disease","volume":"13","author":"Mohajeri","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0825","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000550397","article-title":"Macrophages in Ulcerative Colitis: Immunomodulatory Roles, Phenotypic Switching, and Therapeutic Targeting","volume":"18","author":"Zhao","year":"2026","journal-title":"J. Innate. Immun."},{"key":"10.1016\/j.intimp.2026.116991_bb0830","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.2147\/IJN.S430877","article-title":"Advancements in macrophage-targeted drug delivery for effective disease management","author":"Liu","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.intimp.2026.116991_bb0835","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3389\/fimmu.2017.01520","article-title":"Molecular mechanisms modulating the phenotype of macrophages and microglia","volume":"8","author":"Amici","year":"2017","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116991_bb0840","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/CVI.00328-07","article-title":"Differentiation of C2D macrophage cells after adoptive transfer","volume":"15","author":"Potts","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116991_bb0845","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211846","article-title":"Single-cell transcriptomic analysis of human colonic macrophages reveals niche-specific subsets","volume":"219","author":"Domanska","year":"2022","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.intimp.2026.116991_bb0850","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1136\/gutjnl-2024-334165","article-title":"Single-cell omics in inflammatory bowel disease: recent insights and future clinical applications","volume":"74","author":"Gudi\u00f1o","year":"2025","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.intimp.2026.116991_bb0855","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","article-title":"p53 inhibits CRISPR\u2013Cas9 engineering in human pluripotent stem cells","volume":"24","author":"Ihry","year":"2018","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.intimp.2026.116991_bb0860","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR\u2013Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nature biotechnology"},{"issue":"2","key":"10.1016\/j.intimp.2026.116991_bb0865","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/gastroent17020032","article-title":"Fibrosis in Crohn's Disease: Emerging Pathophysiological Mechanisms and New Therapeutic Targets","volume":"17","author":"Yag\u00fce Caballero","year":"2026","journal-title":"Gastroenterol. Insights"},{"issue":"1","key":"10.1016\/j.intimp.2026.116991_bb0870","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1186\/s12967-026-07969-7","article-title":"IL1\u03b2+ macrophages promote intestinal fibrosis in Crohn\u2019s disease by secreting AREG to activate PI16+ fibroblasts","volume":"24","author":"Xie","year":"2026","journal-title":"J. Transl. Med."},{"issue":"08","key":"10.1016\/j.intimp.2026.116991_bb0875","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/CM9.0000000000003545","article-title":"Intestinal fibrosis associated with inflammatory bowel disease: Known and unknown","volume":"138","author":"Zhang","year":"2025","journal-title":"Chin. Med. J."},{"issue":"7","key":"10.1016\/j.intimp.2026.116991_bb0880","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41588-025-02225-y","article-title":"Single-cell and spatial transcriptomics of stricturing Crohn's disease highlights a fibrosis-associated network","volume":"57","author":"Kong","year":"2025","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.intimp.2026.116991_bb0885","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/amh70030036","article-title":"Microbiome-targeted therapies in gastrointestinal diseases: clinical evidence and emerging innovations","volume":"70","author":"Lim","year":"2025","journal-title":"Acta Microbiol. Hellen."},{"issue":"13","key":"10.1016\/j.intimp.2026.116991_bb0890","doi-asserted-by":"crossref","first-page":"2413197","DOI":"10.1002\/advs.202413197","article-title":"Advances in fecal microbiota transplantation for gut dysbiosis-related diseases","volume":"12","author":"Hou","year":"2025","journal-title":"Adv. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926008374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926008374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:35:56Z","timestamp":1784230556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926008374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":178,"alternative-id":["S1567576926008374"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116991","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage plasticity as a therapeutic target in inflammatory bowel disease: Immunomodulatory and regenerative strategies","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116991"}}